They checked mine after 2 months
September 21 (edited)
The timing of marker response during induction therapy can vary from person to person, and there isn't a fixed number of cycles after which markers are expected to respond positively. Most people with myeloma respond well to their first-line therapy, with responses typically seen over the first two to three years.
Key Show Full Answer
The timing of marker response during induction therapy can vary from person to person, and there isn't a fixed number of cycles after which markers are expected to respond positively. Most people with myeloma respond well to their first-line therapy, with responses typically seen over the first two to three years.
Key markers doctors track include:
- M protein — an abnormal protein made by myeloma cells
- Calcium levels — elevated levels can signal disease activity
- Kidney function — myeloma can affect how well kidneys work
- Hemoglobin levels — to check for anemia
- Bone lesions — areas of bone damage or weakening
Response is assessed using criteria from the International Myeloma Working Group (IMWG), and your doctor will regularly monitor these markers throughout treatment.
It's really important to have an open conversation with your hematologist-oncologist about what response timeline to expect based on your specific treatment regimen, as this can differ depending on the drug combination being used.
September 21
Join
Your Privacy Choices
